These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 1966705)

  • 1. Expression of HBV envelope and nucleocapsid proteins in human cells using vaccinia virus vectors.
    Mondelli M; Baldick J; McLachlan A; Chisari FV; Moss B
    Ital J Gastroenterol; 1990 Jun; 22(3):115-7. PubMed ID: 1966705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirements for optimal expression of secreted and nonsecreted recombinant proteins in vaccinia virus systems.
    Pfleiderer M; Falkner FG; Dorner F
    Protein Expr Purif; 1995 Oct; 6(5):559-69. PubMed ID: 8535147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of hepatitis C viral structure protein by recombinant vaccinia virus].
    Wang X; Tan W; Cong X; Guo K
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):340-3. PubMed ID: 15617243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redirecting retroviral tropism by insertion of hepatitis B virus PreS1 core peptide into the envelope.
    Qi P; Han JX; Lu YQ; Wang CX
    Arch Virol; 2007; 152(9):1721-30. PubMed ID: 17520321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and secretion of preS containing hepatitis B surface antigen in vaccinia virus system.
    Wang YA; Wang SQ; Feng ZM; Zhong WW; Kong YY; Li ZP; Lu XY; Yao GB
    Sci China B; 1990 Sep; 33(9):1070-7. PubMed ID: 2173617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
    Blanchet M; Sureau C
    J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of feline immunodeficiency virus (FIV) gag gene in vaccinia virus vector.
    Wojcik J
    Acta Microbiol Pol; 1995; 44(2):191-6. PubMed ID: 8906935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of compounds that inhibit the interaction between core and surface protein of hepatitis B virus.
    Asif-Ullah M; Choi KJ; Choi KI; Jeong YJ; Yu YG
    Antiviral Res; 2006 Jun; 70(2):85-90. PubMed ID: 16487605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein.
    Yaswen LR; Stephens EB; Davenport LC; Hutt-Fletcher LM
    Virology; 1993 Aug; 195(2):387-96. PubMed ID: 8393232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
    Ren S; Nassal M
    J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of precore and core proteins of hepatitis B virus in human hepatoma cell line].
    Liu DX; Dai L; Luo KX
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):174-6. PubMed ID: 12390822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation.
    Guo H; Jiang D; Zhou T; Cuconati A; Block TM; Guo JT
    J Virol; 2007 Nov; 81(22):12472-84. PubMed ID: 17804499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-HBV effects of genetically engineered replication-defective HBV with combined expression of antisense RNA and dominant negative mutants of core protein and construction of first-generation packaging cell line for HBV vector].
    Sun DX; Hu DR; Wu GH; Hu XL; Li J; Fan GR
    Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):260-4. PubMed ID: 12223133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stable expression of HBV C gene mutants in immortalized human B-cell lines].
    Zhang MX; Zhou FY; Diao ZH; He HT; Hou JL; Luo KX
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):725-9. PubMed ID: 16793585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
    Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Envelopment of the hepatitis B virus nucleocapsid.
    Bruss V
    Virus Res; 2004 Dec; 106(2):199-209. PubMed ID: 15567498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of envelope glycoprotein (E) of Japanese encephalitis virus by recombinant vaccinia virus.
    Haishi S; Imai H; Hirai K; Igarashi A; Kato S
    Acta Virol; 1989 Dec; 33(6):497-503. PubMed ID: 2576591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus.
    Cheng KC; Smith GL; Moss B
    J Virol; 1986 Nov; 60(2):337-44. PubMed ID: 2430108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-containing and empty hepatitis B virus core particles bind similarly to envelope protein domains.
    Hourioux C; Touzé A; Coursaget P; Roingeard P
    J Gen Virol; 2000 Apr; 81(Pt 4):1099-101. PubMed ID: 10725437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.